<SEC-DOCUMENT>0001193125-15-320046.txt : 20150915
<SEC-HEADER>0001193125-15-320046.hdr.sgml : 20150915
<ACCEPTANCE-DATETIME>20150915084105
ACCESSION NUMBER:		0001193125-15-320046
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150914
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150915
DATE AS OF CHANGE:		20150915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REPLIGEN CORP
		CENTRAL INDEX KEY:			0000730272
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				042729386
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14656
		FILM NUMBER:		151106825

	BUSINESS ADDRESS:	
		STREET 1:		41 SEYON STREET
		STREET 2:		BUILDING 1, SUITE 100
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		7814499560

	MAIL ADDRESS:	
		STREET 1:		41 SEYON STREET
		STREET 2:		BUILDING 1, SUITE 100
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d45358d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION&nbsp;13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): September&nbsp;14, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>REPLIGEN CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-14656</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>04-2729386</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>41 Seyon Street, Bldg. 1, Suite 100, Waltham, MA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>02453</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code (781)&nbsp;250-0111 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report.) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2015, Glenn Muir was elected to the Board of Directors (the
&#147;Board&#148;) of Repligen Corporation (the &#147;Company&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Muir will receive cash and equity compensation pursuant to the
Company&#146;s non-employee director compensation policy as set forth in the Company&#146;s Amended and Restated Non-Employee Directors&#146; Compensation Policy (the &#147;Director Compensation Policy&#148;). Pursuant to the terms of the Director
Compensation Policy, Mr.&nbsp;Muir received an option to purchase 24,000 shares of Common Stock on the date he joined the Board (the &#147;Initial Board Option&#148;). The Initial Board Option vests equally over a three-year period from the date of
grant. The Initial Board Option has a term of ten years, subject to early termination in the event of death, removal or resignation from the Board. The Initial Board Option has an exercise price equal to the closing price of the stock on the date
the Initial Board Option was granted. In addition, under the Director Compensation Policy, each non-employee director receives an annual retainer for service on the Board and committees of the Board, and each non-employee director reelected to the
Board by the stockholders is awarded annually restricted stock units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&nbsp;Muir&#146;s appointment to the Board, he has been named
to the Audit Committee of the Board (the &#147;Audit Committee&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Mr.&nbsp;Muir and any other
persons pursuant to which Mr.&nbsp;Muir was selected as a director. There have been no transactions since the beginning of the Company&#146;s last fiscal year, or any currently proposed transaction, in which the Company was or is to be a
participant, in which the amount involved exceeds $120,000, and in which Mr.&nbsp;Muir had, or will have, a direct or indirect material interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company has issued a press release announcing Mr.&nbsp;Muir&#146;s election to the Board and has attached a copy of such press release as Exhibit 99.1 hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&nbsp;Muir&#146;s election to the Board and appointment to the Audit Committee, the number of directors constituting the Board has been
increased to eight and the number of directors constituting the Audit Committee has been increased to four. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. Financial Statements and
Exhibits. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release by Repligen Corporation, dated September&nbsp;15, 2015.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">REPLIGEN CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: September&nbsp;15, 2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tony J. Hunt</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tony J. Hunt</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:11.80pt; font-size:8pt; font-family:Times New Roman"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release by Repligen Corporation, dated September 15, 2015.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d45358dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g45358snap1.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repligen&nbsp;Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">41 Seyon
Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Building&nbsp;#1,&nbsp;Suite&nbsp;100</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Waltham,&nbsp;Massachusetts&nbsp;02453</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Repligen Appoints Glenn P. Muir to Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WALTHAM, MA &#150; September 15, 2015</B> &#150; Repligen Corporation (NASDAQ:RGEN) today announced that life sciences industry veteran Glenn P. Muir has
been elected to its Board of Directors and appointed as a member of its Audit Committee. Mr. Muir brings over 30 years of experience to the director role, most recently as Chief Financial Officer and Executive Vice President, Finance and
Administration for Hologic, Inc. (NASDAQ:HOLX), a large multi-national medical device and diagnostics company where he was instrumental to the company&#146;s significant expansion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are very pleased to welcome Mr. Muir as a member of our Board,&#148; said Tony J. Hunt, President and Chief Executive Officer of Repligen. &#147;Mr.
Muir has been integral to the acquisition and integration of over twenty companies and technologies. He recognizes the importance of establishing technology leadership in an evolving marketplace. As Repligen continues to grow and diversify, we are
confident that Mr. Muir&#146;s experience will contribute to the realization of our goal to be a best-in-class bioprocessing company.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr. Muir
retired in May 2014 from Hologic, Inc., where he helped steer the company&#146;s evolution from a venture-backed single product company to a publicly traded diversified organization with over 5,000 employees and $2.5 billion in revenue. He joined
Hologic in 1988 and served as CFO since 1992 and Executive Vice President since 2000. Prior to Hologic, Mr. Muir was with Metallon Engineered Materials Co., a private company where from 1986-1988 he held the role of Vice President, Finance.
Previously, from 1981-1984, he was a Senior Auditor with Arthur Andersen &amp; Co. Mr. Muir is a Certified Public Accountant with a Bachelors of Business Administration from the University of Massachusetts, Amherst. He also earned a Masters of
Science from Bentley University and a Masters of Business Administration from Harvard University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, Mr. Muir also serves on the boards of
medical device company ReWalk Robotics Ltd. (NASDAQ:RWLK) and genomic tool company RainDance Technologies, Inc. His previous board memberships include Hologic, Inc. and airline inspection system company Vivid Technologies, Inc. In 2011, Mr. Muir was
named &#147;CFO of the Year&#148; by <I>Boston Business Journal</I> and in 2009, he was recognized by <I>Institutional Investor</I> as one of &#147;America&#146;s Best CFOs&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- more - </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Repligen Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repligen Corporation (NASDAQ:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the
process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A media
that is used to separate and purify monoclonal antibody therapeutics. Our ATF System and our growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market
an innovative line of &#147;ready-to-use&#148; chromatography columns under our OPUS<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> brand that we deliver pre-packed with our customers&#146; choice of purification media. Repligen&#146;s
corporate headquarters are in Waltham, MA (USA) and our manufacturing facilities are located in Waltham, MA and Lund, Sweden. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release may
contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by
words like &#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;seek,&#148; or &#147;could&#148; and similar expressions, constitute forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim
any responsibility to update any forward-looking statements, except as required by law.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repligen Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sondra Newman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(781) 419-1881 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>snewman@repligen.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"># # # </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g45358snap1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g45358snap1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M*"E&4HU.>+LOCG_AV-\!?^AM^+O_ (/O!G_S U]7_P 1#SK_ *!<%_X+K_\
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M?FOB'_S)_P#N:_\ =8]U^#W[:/[-'A7X2?"WPQKWQ)^P:YX;^'/@C0=9L?\
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MC^?\$P]KGF-Q&'I3PV%C1JM0B_:0A&I5A[*A.K.#D[13E%IPJ3=&]W%5(O\
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MG_[#<)_Z?IG9G/\ R)\V_P"P/%?^F)GXM_L6?M.> OV<?^%E?\)OI'B_5/\
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MZ>']][KWE\%FNJG:23:349;V:?\ 3'7YR?:!0!\B_M4_LK?\-,_\()_Q7?\
MPA/_  A/_"4?\RO_ ,))_:?_  D?_"._]3%I?V+[-_8'_3?S/M?_ "S\K]Y]
M1PUQ)_J[]=_V+ZW];]C_ ,OO9<GLO:_].JG-S>T_NVY>M]/FN(>'O[>^I_[9
M]4^J>U_Y=>UYO:^S_P"GE/EY?9^=[]+:_1?P^\*_\()X"\$>"/M_]J?\(;X0
M\->%?[3^R_8?[1_X1[1K+2/M_P!B^T7'V/[1]C\WR//G\OS-GF/MW-X..Q/U
MW&XS&<GLOK=>K6Y+\W)[6I*?+S6CS<O-:_*KVO9;'N8+#_4\'A,)S^T^JT:5
M'GMR\WLX1AS<MY<O-RWM=VO:[W/E']H;]B^P^-?Q#T'XH^&?B#>?"WQAI=G8
MP7^I:3X;AU&;4;_0[I;GP[XA@O-/UK1;VQ\1V*8MC?R7=X[6^G:3% +4:=FX
M^FR+BV>3X"MEN(P,<QPM24G&$ZK@H1J*U6DXRIUH2I3^+D48)2E5<N?VGN_.
M9UPM#-<;1S##XV67XFE&*E*%)2<I4W>E44HSI3C5A\/.Y2?+&FH\G)[WUUX1
MT_Q+I/AK1]-\8>(K/Q=XDL;-;;5?$UCH">%X=;FB=TCU!]!BU._AT^\EMQ";
MA;>X%N]QYTEO!:P21VMO\OBIX>IB*M3"T)83#RE>%&53VKII[Q]HX0<HIWY>
M:/,HV4I3DG.7TN&A7I4*5/$UXXFO"-IU8T_9*HUM+V:E-1DU;FY9<KE=QC"+
M4(_-'[5/[*W_  TS_P ()_Q7?_"$_P#"$_\ "4?\RO\ \))_:?\ PD?_  CO
M_4Q:7]B^S?V!_P!-_,^U_P#+/ROWGT'#7$G^KOUW_8OK?UOV/_+[V7)[+VO_
M $ZJ<W-[3^[;EZWT\'B'A[^WOJ?^V?5/JGM?^77M>;VOL_\ IY3Y>7V?G>_2
MVOR)_P .K?\ JN__ )C#_P#&'7U/_$2?^I+_ .7?_P!ZGS7_ !#S_J;_ /EK
M_P#?)Z[\"/V ?^%)?%;PK\3O^%L_\)-_PC/]N?\ $C_X03^Q?MO]L^&]8\/_
M /(2_P"$ROOLWD_VK]H_X]9=_P!G\OY-^]/*SKC?^U\LQ.7?V9]7]O[/]Y]9
M]IR^SJPJ_!["%[\G+\2M>^MK/T\GX-_LK,</C_[1]O[#VG[OZOR<W/2G3^+V
M\[6Y[_"[VMI>Z_1BO@S[<^%O!'[%G_"&_M)WO[0O_"RO[1^U^+_B#XJ_X1#_
M (0W['Y?_"=6OB6U^P?V_P#\)5/O^P_\)#N\_P#LU?/^QX\N'S<Q_98SB[ZW
MP_#(O[/]GRT,-1]O[>_^[ND^;V?L5\?LK6]I[O-O*VOR.$X5^J9[+.OK_/S5
ML16]C["W^\*JN7VGMG\'M-^3WN7:-]/NFOC3ZX* /(OCO\*O^%V?"GQ5\,?[
M>_X1G_A)O[#_ .)W_9?]L_8?[%\2:/X@_P"0;_:-C]I\[^R?L_\ Q]1;//\
M,^;9L?U,ES+^Q\SPV8^Q^L?5_:?N^?V?-STITOCY9VMS\WPN]K:7NO-S?+O[
M4R[$8#VWL/;^S_><G/R\E6%3X>:%[\EOB5KWUM9_G/\ \.K?^J[_ /F,/_QA
MU][_ ,1)_P"I+_Y=_P#WJ?#_ /$//^IO_P"6O_WR=?\ #[_@FO\ \()X]\$>
M-_\ A=']J?\ "&^+_#7BK^R_^%=?8?[1_P"$>UFRU?[!]M_X3NX^Q_:/L?E>
M?Y$_E^9O\M]NUN7'>('UW!8S!_V3[+ZW0JT>?ZUS<GM:<H<W+]7CS<O->W,K
MVM=;G5@N!?J>,PF+_M3VGU6M2K<GU;EYO9SC/EYOK$N7FY;7L[7O9['ZC5^<
M'Z ?"W[,?[%G_#./CW5_&_\ PLK_ (3+^U/"%_X5_LO_ (0W_A'OL_V[6= U
M?[?]M_X2K4_-V?V'Y7D>0F[[5O\ ,'E[9/LN(N+O[>P5+!_V?]4]E7C6Y_;^
MUORTZD.7E]C3M?VE[\SM:UM;KY'(.%?[#QE3%_7_ *UST94>3V'L[7G3GS<W
MMJE[>SM:RWO?2S^Z:^-/KCX6^.?[ _PM^,&O:[XTTC5M7^'GC/7?LT][<:1:
M:?J/A2\U47HFU/7M3\,2QVMQ/J]_9M+'-)9:OIT<ER$OYHI[F2[:_P#LLFXU
MS+*J%'!U:4,=A*%U%3E*%:,.6T*<*J<HJ$)6<5.E4:A>G&48*"A\CF_!V7YE
M6K8JE4G@L56LY."C*BY\UYU)TFHR<YQNI.%6"<K5)*4G/G^?]/\ ^"6%A%?V
M,FJ_&V\O-+CO+9]2L]/^'L.EW]U8),C7EM8ZE<^,[^'3KR6W$B17,MC>I"[+
M(UO,J&-_<GXD3<)JED\85'%\DI8ESC&5O=<H*A!RBG9N*G!M:*4;W7C0\/8*
M</:9M*5-27-&.&4).-_>49.O-1DU=*3A))ZN,K6?Z ?!#X!_#S]G[PU=>'/
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MC</]<P>+PG/[/ZU1JT>>W-R^TA*'-RWCS<O->UU>UKK<_+G_ (=6_P#5=_\
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MQ>?V/(J6LH!;\1^//$G@CPH/$_C#PKI4?EZMX&TBXT_PEX@U_P 77 N/%OQ
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MW_A#/[<^V?VI_;/_  K_ /MS_A&/[5_MS_B<_:_[(\[^UO\ B;;_ .TO]*H
MZO1M#TOP]9S6&CVOV2TGU;7M<EB\ZXN-^J>)M<U'Q)K=UYEU+(Z_:=:U74+C
MRPPCC\_RX4CB1(T-@V.4_P"%6> QH?\ PC::%Y6BGX?_ /"K)K*'4]9@^V>
MTL_L%KH6HW$.H+/J7V.T>[CLKVZEFO+'^UM4:SN(&U:^-V;!L&E?"_P9I7]I
M;K'5O$']JZ5>:#>_\)SXK\6_$3.AZEY?]KZ-:_\ ">ZYK']GZ5J7V>T^WVEI
MY,-__9]E]L2?[%;^2;!L%U\,?"E[X?E\,7S>*[_29O[#;_B8?$+X@7VJ0W'A
MOQ)-XNT74+37[OQ/)JECJUKKTR3C4+>\BNGCL=/M9)GM--LX+8V#8+7X9^'+
M.WAM8M2^(+1P?VWL:Z^+/Q4O;@_\)!I<.D7_ )MW>^,Y9[CRK2WCDL?-D?\
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H % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
